Skip to main content

Simulating Delay in Seeking Treatment for Stroke Due to COVID-19 Concerns with a Hybrid Agent-Based and Equation-Based Model

  • Conference paper
  • First Online:
Advances in Social Simulation

Abstract

COVID-19 has caused strain on healthcare systems worldwide and concern within the population over this strain and the chances of becoming infected has reduced the likelihood of people seeking medical treatment for other health events. Stroke is a medical emergency and swift treatment can make a difference in outcomes. Understanding how concern over the COVID-19 pandemic impacts the time delay in seeking treatment after a stroke can help understand both the long-term cost implications and how to target individuals to remind them of the importance of seeking treatment. We present an agent-based model to simulate the delay in seeking treatment for stroke due to concerns over COVID-19 and show that small changes in behaviour impact the average delay in seeking treatment. We find that introducing control measures and having multiple smaller peaks of the pandemic results in less delay in seeking treatment compared to a scenario with one large peak.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Notes

  1. 1.

    Those age 50 and older make up approximately 30.4\(\%\) of the Irish population.

References

  1. Amárach Research.: Public opinion tracking research: 10/05/21. Department of Health (2020). https://www.gov.ie/en/collection/6b4401-view-the-amarach-public-opinion-survey/. Accessed 13 May 2021

  2. Brant, L.C.C., et al.: Excess of cardiovascular deaths during the covid-19 pandemic in Brazilian capital cities. Heart 106(24), 1898–1905 (2020). https://doi.org/10.1136/heartjnl-2020-317663, https://heart.bmj.com/content/106/24/1898

  3. Conroy, R., et al.: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Hear. J. 24(11), 987–1003 (2003). https://doi.org/10.1016/S0195-668X(03)00114-3

    Article  Google Scholar 

  4. CSO: Census 2011 boundary files (2014). http://www.cso.ie/en/census/census2011boundaryfiles/. Accessed 26 May 2016

  5. D’Agostino, R.B., Wolf, P.A., Belanger, A.J., Kannel, W.B.: Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 25(1), 40–43 (1994). https://doi.org/10.1161/01.STR.25.1.40

    Article  Google Scholar 

  6. Dhand, S., O’Connor, P., Hughes, C., Lin, S.P.: Acute ischemic stroke: acute management and selection for endovascular therapy. Semin. Interv. Radiol. 37(02), 109–118 (2020). https://doi.org/10.1055/s-0040-1709152

    Article  Google Scholar 

  7. Girotra, T., Lekoubou, A., Bishu, K.G., Ovbiagele, B.: A contemporary and comprehensive analysis of the costs of stroke in the United States. J. Neurol. Sci. 410, 116643 (2020). https://doi.org/10.1016/j.jns.2019.116643

  8. Gleeson, J.P., Murphy, T.B., O’Brien, J.D., O’Sullivan, D.J.P.: A population-level SEIR model for covid-19 scenarios (updated). In: Irish Epidemiological Modelling Advisory Group to NPHET - Technical Notes (2020). https://www.gov.ie/en/publication/dc5711-irish-epidemiology-modelling-advisory-group-to-nphet-technical-notes/. Accessed 13 May 2021

  9. Gumbinger, C., et al.: Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials. BMJ 348 (2014). https://doi.org/10.1136/bmj.g3429. BMJ Publishing Group Ltd

  10. Hoyer, C., et al.: Acute stroke in times of the COVID-19 pandemic: a multicenter study. Stroke 51(7), 2224–2227 (2020). https://doi.org/10.1161/STROKEAHA.120.030395

    Article  Google Scholar 

  11. Hunter, E., Kelleher, J.D.: A framework for validating and testing agent-based models: a case study from infectious diseases modelling. In: 34th annual European Simulation and Modelling Conference (2020). https://doi.org/10.21427/2xjb-cq79

  12. Hunter, E., Mac Namee, B., Kelleher, J.D.: A taxonomy for agent-based models in human infectious disease epidemiology. J. Artif. Soc. Soc. Simul. 20(3), 2 (2017). https://doi.org/10.18564/jasss.3414, http://jasss.soc.surrey.ac.uk/20/3/2.html

  13. Johnson, C.O., et al.: Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 18(5), 439–458 (2019). https://doi.org/10.1016/S1474-4422(19)30034-1. Elsevier

  14. Joo, H., George, M.G., Fang, J., Wang, G.: A literature review of indirect costs associated with stroke. J. Stroke Cereb.Vascular Dis.: Off. J. Natl. Stroke Assoc. 23(7), 1753–1763 (2014). https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.02.017

    Article  Google Scholar 

  15. Khosravani, H., et al.: Protected code stroke: hyperacute stroke management during the coronavirus disease 2019 (COVID-19) pandemic. Stroke 51(6) (2020). https://doi.org/10.1161/STROKEAHA.120.029838

  16. Lees, K.R., et al.: Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (London, England) 375(9727), 1695–1703 (2014). https://doi.org/10.1016/S0140-6736(10)60491-6

    Article  Google Scholar 

  17. Liu, R., Zhao, J., Fisher, M.: The global impact of COVID’19 on acute stroke care. CNS Neurosci. Ther. 26(10), 1103–1105 (2020). https://doi.org/10.1111/cns.13442, https://onlinelibrary.wiley.com/doi/10.1111/cns.13442

  18. Mandelzweig, L., Goldbourt, U., Boyko, V., Tanne, D.: Perceptual, social, and behavioral factors associated with delays in seeking medical care in patients with symptoms of acute stroke. Stroke 37(5), 1248–1253 (2006). https://doi.org/10.1161/01.STR.0000217200.61167.39. American Heart Association

  19. Matsuo, R., et al.: Association between onset-to-door time and clinical outcomes after ischemic stroke. Stroke 48(11), 3049–3056 (2017). https://doi.org/10.1161/STROKEAHA.117.018132

    Article  Google Scholar 

  20. McCormack, R.C.J.: National Stroke Register Report 2018. National Clinical Programme for Stroke (NCPS) (2018). https://www.hse.ie/eng/about/who/cspd/ncps/stroke/resources/2018-national-stroke-register-report.pdf. Accessed 13 May 2021

  21. McGurgan, I.J., et al.: Acute intracerebral haemorrhage: diagnosis and management. Pract. Neurol. 21(2) (2021). https://doi.org/10.1136/practneurol-2020-002763. BMJ Publishing Group Ltd

  22. Parry-Jones, A.R., et al.: An intracerebral hemorrhage care bundle is associated with lower case fatality. Ann. Neurol. 86(4), 495–503 (2019). https://doi.org/10.1002/ana.25546

    Article  Google Scholar 

  23. Rajsic, S., et al.: Economic burden of stroke: a systematic review on post-stroke care. Eur. J. Health Econ. 20(1), 107–134 (2019). https://doi.org/10.1007/s10198-018-0984-0

    Article  Google Scholar 

  24. Sacco, R.L., et al.: An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44(7), 2064–2089 (2013). https://doi.org/10.1161/STR.0b013e318296aeca

    Article  Google Scholar 

  25. Wein, T.H., et al.: Activation of emergency medical services for acute stroke in a nonurban population. Stroke 31(8), 1925–1928 (2000). https://doi.org/10.1161/01.STR.31.8.1925. American Heart Association

  26. Woolf, S.H., et al.: Excess deaths from COVID-19 and other causes, March-July 2020. JAMA 324(15), 1562–1564 (2020). https://doi.org/10.1001/jama.2020.19545

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elizabeth Hunter .

Editor information

Editors and Affiliations

Ethics declarations

This project received funding from the EU’s Horizon 2020 research and innovation programme under grant agreement No. 777107, and by the ADAPT Centre for Digital Content Technology funded under the SFI Research Centres Programme (Grant 13/RC/2106_P2) and co-funded under the European Regional Development Funds.

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Hunter, E., McGarry, B.L., Kelleher, J.D. (2022). Simulating Delay in Seeking Treatment for Stroke Due to COVID-19 Concerns with a Hybrid Agent-Based and Equation-Based Model. In: Czupryna, M., Kamiński, B. (eds) Advances in Social Simulation. Springer Proceedings in Complexity. Springer, Cham. https://doi.org/10.1007/978-3-030-92843-8_29

Download citation

Publish with us

Policies and ethics